- Somatostatin analog and mTOR inhibitor treatment of Merkel cell tumor2012 | Faculty of Medicine in Hradec Králové
- Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021)2022 | Publication without faculty affiliation
- Administration of Nivolumab in Metastatic Renal Cell Cancer Following Treatment With mTOR Inhibitors2021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Oral cavity mucosa damage after chemotherapy and mTOR inhibitors treatment2015 | Faculty of Medicine in Pilsen
- Pharmacokinetic principles of dose adjustment of mTOR inhibitors in solid organ transplanted patients2022 | First Faculty of Medicine
- mTOR inhibitor improves autistic-like behaviors related to Tsc2 haploinsufficiency but not following developmental status epilepticus2021 | First Faculty of Medicine, Faculty of Science, Faculty of Physical Education and Sport, Central Library of Charles University
- Stomatitis in mtor inhibitors treatment and other targeted cancer therapy, possibilities of influencing it, and the use of local corticotherapy2020 | Faculty of Medicine in Pilsen
- mTOR as an eligible molecular target for possible pharmacological treatment of nonalcoholic steatohepatitis2022 | First Faculty of Medicine
- Severe Hyperinsulinaemic Hypoglycaemia in Beckwith-Wiedemann Syndrome due to Paternal Uniparental Disomy of 11p15.5 Managed with Sirolimus Therapy2016 | Second Faculty of Medicine
- Sequential treatment of metastatic renal carcinoma2014 | First Faculty of Medicine
- The Role of Green Tea Catechin Epigallocatechin Gallate (EGCG) and Mammalian Target of Rapamycin (mTOR) Inhibitor PP242 (Torkinib) in the Treatment of Spinal Cord Injury2023 | Second Faculty of Medicine
- Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Treatment of gastrointestinal stromal tumours2010 | Second Faculty of Medicine
- Rapamycin: Drug Repurposing in SARS-CoV-2 Infection2021 | Faculty of Medicine in Hradec Králové
- Systemic therapy for advanced clear cell renal cell carcinoma in 20132014 | Publication without faculty affiliation
- New trends in renal nagiomyolipomas therapy2015 | Faculty of Medicine in Pilsen
- Strategies for managing endocrine resistance in advanced hormone receptor-positive and HER2-negative breast cancer2017 | First Faculty of Medicine
- Kidney cancer. What is the next step after failure of treatment with angiogenesis inhibitors?2010 | Second Faculty of Medicine
- Sequential therapy in metastatic renal cell carcinoma2014 | First Faculty of Medicine
- Nontuberculous mycobacterial infection after therapy with temsirolimus for metastatic renal cell carcinoma2013 | First Faculty of Medicine
- Everolimus in therapy of lung and gastrointestinal neuroendocrine tumors - comments on Radiant-42017 | First Faculty of Medicine
- Everolimus 2nd line palliative biotherapy in a patient with metastatic renal cell cancer with clinically significant manifestation of paraneoplastic polyglobulia2013 | Publication without faculty affiliation
- Immunosuppressive management of Pediatric Kidney Transplant Recipients2020 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Summary of treatment recommendations for metastatic renal cancer2013 | First Faculty of Medicine
- Vinorelbine, a second-generation Vinca alkaloid - its place in the treatment of advanced and metastatic breast cancer2014 | First Faculty of Medicine
- Combination Treatment Targeting mTOR and MAPK Pathways Has Synergistic Activity in Multiple Myeloma2023 | First Faculty of Medicine
- Patient with kidney carcinoma2017 | First Faculty of Medicine
- An overview of treatment modalities in neuroendocrine neoplasias2013 | First Faculty of Medicine
- Drug induced angioedema2023 | Faculty of Medicine in Hradec Králové
- Cabozantinib in the treatment of RCC2018 | First Faculty of Medicine